U.S. Markets closed
  • S&P Futures

    3,594.50
    +18.50 (+0.52%)
     
  • Dow Futures

    29,727.00
    +181.00 (+0.61%)
     
  • Nasdaq Futures

    11,948.00
    +42.75 (+0.36%)
     
  • Russell 2000 Futures

    1,830.20
    +13.10 (+0.72%)
     
  • Crude Oil

    43.11
    +0.05 (+0.12%)
     
  • Gold

    1,824.50
    -13.30 (-0.72%)
     
  • Silver

    23.37
    -0.26 (-1.11%)
     
  • EUR/USD

    1.1847
    +0.0001 (+0.0118%)
     
  • 10-Yr Bond

    0.8570
    +0.0280 (+3.38%)
     
  • Vix

    22.66
    -1.04 (-4.39%)
     
  • GBP/USD

    1.3330
    +0.0008 (+0.0587%)
     
  • USD/JPY

    104.5630
    +0.0750 (+0.0718%)
     
  • BTC-USD

    18,382.73
    +123.00 (+0.67%)
     
  • CMC Crypto 200

    367.97
    +6.54 (+1.81%)
     
  • FTSE 100

    6,333.84
    -17.61 (-0.28%)
     
  • Nikkei 225

    26,174.18
    +646.81 (+2.53%)
     

Intra-Cellular Therapies to Present at the Cantor Virtual Global Healthcare Conference

Intra-Cellular Therapies Inc.
·1 min read

NEW YORK, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to participate in a fireside chat at the Cantor Virtual Global Healthcare Conference on Tuesday, September 15, 2020 at 10:00 am ET.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.

Contact

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
jgrimaldi@burnsmc.com
212-213-0006

Media Inquiries:

Ana Fullmer
Corporate Media Relations W20wcg
afullmer@wcgworld.com
202-507-0130